CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (95,529)	$ 8,402
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	16,160	10,366
Amortization of inventory step-up	5,327	0
Inventory impairment charges	398	707
Share-based compensation	23,779	21,182
Amortization of discount and cost of issuance of debt	500	150
Bad debts	0	24
(Gain) loss from change in fair value of warrants	22,286	(67,654)
(Gain) loss from change in fair value of contingent considerations and acquisition-related holdbacks	(673)	(3,667)
Deferred City Semi compensation	0	125
Deferred tax liabilities	(3,716)	0
Amortization of right-of-use assets	1,196	1,118
Unrealized foreign currency transaction gain	(43)	(216)
Changes in operating assets and liabilities:
Accounts receivable	(5,887)	(1,753)
Inventory	(15,476)	(2,448)
Accounts payable	(1,691)	1,945
Accrued expenses and other current liabilities	(6,825)	434
Accrued payroll liabilities	969	(723)
Deferred revenue	(891)	457
Prepaid and other current assets	(11,381)	(2,340)
Operating lease liabilities	(935)	(814)
Other long-term liabilities	(708)	(2,177)
Net cash used in operating activities	(73,140)	(36,882)
Cash flows from investing activities:
Purchases of property and equipment	(6,564)	(1,846)
Business combinations, net of cash acquired	(98,429)	(8,705)
Net cash used in investing activities	(104,993)	(10,551)
Cash flows from financing activities:
Proceeds from issuance of common stock/At-the-market offering	51,998	0
Proceeds from issuance of debt obligations	0	1,059
Payments on debt obligations	(12,169)	(1,050)
Payments on financed software	(4,135)	(1,928)
Deferred payments on business combination	0	(5,000)
Payments of City Semi deferred compensation	0	(1,000)
Proceeds from exercise of stock options	31	72
Net cash provided by (used in) financing activities	35,725	(7,847)
Effect of exchange rate changes on cash and cash equivalents	1,189	(52)
Net decrease in cash and cash equivalents	(141,219)	(55,332)
Cash, cash equivalents and restricted cash at beginning of period	321,879	219,464
Cash, cash equivalents and restricted cash at end of period	180,660	164,132
Supplemental disclosure of cash flow information:
Cash paid for interest	3,654	128
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	(649)	275
Fair value of common stock issued for business combination	85,391	0
Fair value of common stock issuable for business combination	20,979	0
Contingent consideration for business combination	73,072	8,204
Accrual for purchase consideration for business combination	$ 4,264	$ 9,674